Pay in 4 interest-free payments of $5.88 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Preliminary results from the SURPASS-J-mono study in Japanese patients with T2D who were either therapy nave or on an antidiabetic monotherapy showed a head-to-head comparison of a tirzepatide treatment compared to therapy with the GLP-1RA dulaglutide at a dose of 0.75 mg (76)
But heres the thing: using smaller doses for weight loss hasnt been rigorously studied
Status epilepticus in the ICU
Patients between 18 and 84 years were eligible for the analysis if they were new users of GLP1 or DPP4
US$ 25.78
US$ 22.82
US$ 20.45
US$ 20.45
US$ 25.30
US$ 28.29
